ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: Summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ...

The company is trying to develop a one-time treatment for forms of heart disease that afflict more than 1 million people in ...

The following is a summary of “Impact of frailty on outcomes following coronary artery bypass grafting: a systematic review ...

Heart Hospital has expanded its use of surgical robots incoronary artery bypass grafting (Robotic CABG) surgeries.

Heart Hospital has expanded its use of surgical robots in coronary artery bypass grafting (Robotic CABG) ...

The company will use the proceeds to test its gene therapy XC001 in two Phase II studies involving patients with cardiovascular disease.

Robotic-assisted coronary artery bypass grafting surgeries offer a less invasive and more precise alternative to traditional ...

The following is a summary of “Percutaneous coronary intervention of the left main coronary artery bifurcation: Insights from the PROGRESS-BIFURCATION registry,” published in the December 2024 issue ...

US clinical-stage biotech XyloCor Therapeutics has announced the completion of a $67.5 million Series B financing.

Series B financing in XyloCor Therapeutics to develop Novel Gene Therapy in Cardiovascular Disease Proceeds of financing will ...